RecruitingNCT03781401

Telemonitoring of Blood Pressure in Local Pharmacies

Blood Pressure Telemonitoring in Local Pharmacies and Blood Pressure Control in the Community

Sponsor

Italian Institute of Telemedicine

Enrollment

40,000 participants

Start Date

Oct 1, 2010

Study Type

OBSERVATIONAL

Conditions

Hypertension

Summary

The TEMPLAR project is an observational, cross-sectional, multicenter study involving several community pharmacies spread all over Italy. The aim of the project, the currently largest Italian ABPM Registry, is to analyze the 24-hour ABPMs performed in community pharmacies enabled for this service in accordance with the current Italian regulations, in order to evaluate the level of BP control in the community and to provide scientific evidence on the usefulness of a telehealth network involving the pharmacist for the screening and control of hypertension.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study is evaluating whether 24-hour ambulatory blood pressure monitoring (ABPM) — a small wearable device that automatically measures your blood pressure throughout the day and night — can be conveniently and accurately performed in local pharmacies rather than in traditional hospital or clinic settings. If pharmacies can reliably deliver this type of monitoring, it could make blood pressure care more accessible to more patients. The study will compare pharmacy-based readings with clinically expected values for patients who have been referred for this type of monitoring. **You may be eligible if...** - You are a patient of any age or sex - Your doctor has recommended 24-hour blood pressure monitoring (ABPM) as part of your care - You may be on blood pressure medication or not — both are accepted **You may NOT be eligible if...** - There are no specific exclusion criteria listed — most patients referred for ABPM monitoring may qualify for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.